DAFNA Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

DAFNA Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,047	Closed	-$1.66M	–	95
2015 Q2	$1.66M	Sell	2,047 -29	-1%	-$18.6K	1.4%	25
2015 Q1	$1.53M	Buy	2,076 +4	+0.2%	+$2.56K	1.18%	24
2014 Q4	$1.4M	Buy	+2,072	New	+$1.56M	1.1%	25

Other funds holding EVFM

Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DAFNA Capital Management's EVFM Position: Q3 2015 in Review

DAFNA Capital Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2015, closing a stake of 2,047 shares — an estimated $1.66M sold.

DAFNA Capital Management first reported a position in EVFM in Q4 2014 and held it in 3 quarters. The position peaked at $1.66M in Q2 2015. 29 funds tracked by Wall St. Rank hold EVFM as of Q3 2015.

DAFNA Capital Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
DAFNA Capital Management sold 2,047 Evofem Biosciences, Inc. Common Stock shares in Q3 2015, an estimated $1.66M.
DAFNA Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 3 quarters.
DAFNA Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $1.66M in Q2 2015.
29 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2015.

Based on DAFNA Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.